Novavax, Inc. (NVAX)
10.22
-0.12
(-1.16%)
USD |
NASDAQ |
Sep 04, 16:00
10.19
-0.03
(-0.29%)
After-Hours: 20:00
Novavax Debt to Equity Ratio : -1.559 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.559 |
| March 31, 2026 | -2.038 |
| December 31, 2025 | -2.176 |
| September 30, 2025 | -1.603 |
| June 30, 2025 | 6.073 |
| March 31, 2025 | -3.023 |
| December 31, 2024 | -0.4223 |
| September 30, 2024 | -0.4432 |
| June 30, 2024 | -0.5403 |
| March 31, 2024 | -0.2645 |
| December 31, 2023 | -0.3914 |
| September 30, 2023 | -0.3274 |
| June 30, 2023 | -0.2637 |
| March 31, 2023 | -0.2223 |
| December 31, 2022 | -0.9726 |
| September 30, 2022 | -0.774 |
| June 30, 2022 | -1.076 |
| March 31, 2022 | 6.743 |
| December 31, 2021 | -1.490 |
| September 30, 2021 | 0.9336 |
| June 30, 2021 | 0.5904 |
| March 31, 2021 | 0.4452 |
| December 31, 2020 | 0.7683 |
| September 30, 2020 | 1.451 |
| June 30, 2020 | 0.8398 |
| Date | Value |
|---|---|
| March 31, 2020 | -13.44 |
| December 31, 2019 | -1.784 |
| September 30, 2019 | -1.747 |
| June 30, 2019 | -1.788 |
| March 31, 2019 | -2.261 |
| December 31, 2018 | -1.901 |
| September 30, 2018 | -2.517 |
| June 30, 2018 | -3.631 |
| March 31, 2018 | -3.201 |
| December 31, 2017 | -3.124 |
| September 30, 2017 | -4.280 |
| June 30, 2017 | -5.368 |
| March 31, 2017 | -10.88 |
| December 31, 2016 | -57.04 |
| September 30, 2016 | 6.348 |
| June 30, 2016 | 2.868 |
| March 31, 2016 | 1.702 |
| December 31, 2015 | 0.0013 |
| September 30, 2015 | 0.0015 |
| June 30, 2015 | 0.0018 |
| March 31, 2015 | 0.0021 |
| December 31, 2014 | 0.0043 |
| September 30, 2014 | 0.0061 |
| June 30, 2014 | 0.0064 |
| March 31, 2014 | 0.0105 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Moderna, Inc. | 0.1904 |
| Merck & Co., Inc. | 1.286 |
| Pfizer Inc. | 0.7418 |
| Recursion Pharmaceuticals, Inc. | 0.0728 |
| Agenus, Inc. | -1.458 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 955.58M |
| Total Liabilities (Quarterly) | 1.146B |
| Shareholders Equity (Quarterly) | -190.71M |
| Current Ratio | 2.333 |
| Net Debt Paydown Yield | -0.88% |